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Epidermal development and di¡erentiation are similar
processes and therefore the study of one is likely to
provide insight into the other. The signaling cascades
required for epidermal di¡erentiation are largely un-
known. Recent evidence, however, has implicated two
proteins, p63 and c-Myc, in di¡erent stages of epidermal
development and di¡erentiation. p63 was shown to be
required for embryonic epidermal development. Mice
lacking p63 do not develop strati¢ed epithelia and ap-
pendages suggesting a role for p63 in the commitment
to squamous epithelial lineages. Subsequent stem cell
fate decisions are required to form the di¡erent struc-
tures of strati¢ed epithelia including hair follicles, se-
baceous glands, and epidermis. Several genes of the
Wnt signaling pathway have been implicated in this
process, including c-Myc, a downstream target of the
Wnt pathway. Interestingly, targeted overexpression
of c-Myc in the basal layer of the epidermis results in
an increase in sebaceous gland size and number at the
expense of hair follicles. This suggests that c-Myc
promotes di¡erentiation of epidermal stem cells into
sebaceous glands. In this review, we discuss transgenic/
knockout mouse models that have provided evidence
linking c-Myc and p63 to di¡erent stages of epidermal
development and di¡erentiation. Key words: c-Myc/
epidermal di¡erentiation/p63/stem cells/transgenic/knockout
mice. JID Symposium Proceedings 7:41 ^45, 2002
T
he epidermis, which forms the outer layer of the
skin, is a constantly self-renewing tissue that provides
a fascinating system to study the molecular and cel-
lular mechanisms governing tissue formation and
homeostasis. Despite decades of research, relatively
little is known about the regulatory pathways required for proper
epidermal di¡erentiation. These pathways regulate distinct pro-
cesses such as epidermal stem cell fate decisions, initiation of
epidermal di¡erentiation, and transcriptional control of the dif-
ferentiation process. Interestingly, the process of di¡erentiation
of normal adult epidermis shows striking similarities with the
development of embryonic epidermis, re£ected by the expression
patterns of structural proteins in di¡erent compartments of the
epidermis representing di¡erent stages of maturation. Based on
these similarities, studies on skin development are likely to pro-
vide insight into the regulatory mechanisms governing skin dif-
ferentiation. This review will focus on transgenic/knockout
mouse models that have recently revealed the role of c-Myc and
p63 in stem cell fate decisions and commitment to di¡erentiation.
EPIDERMAL DEVELOPMENT
The signaling cascades responsible for the onset of epidermal
development are poorly understood, but are likely to involve
cross-talk between the ectoderm and the underlying mesen-
chyme. The molecules mediating this cross-talk, however, are
currently unknown. The single-layered ectoderm covering the
body expresses keratin 8 (K8) and K18 ( Jackson et al, 1981). At em-
bryonic day 9.5 (E9.5), prior to the onset of strati¢cation, this
simple epithelium initiates expression of K5, K14, and p63 (Byrne
et al, 1994; Mills et al, 1999; Yang et al, 1999), proteins expressed in
the basal layer of adult epidermis. Shortly after, at E10.5, the ¢rst
stage of epidermal di¡erentiation results in the formation of the
periderm (M’Boneko and Merker, 1988). Further epidermal ma-
turation takes place between E15.5 and E18.5. At E15.5, the epider-
mis forms an intermediate layer between the basal layer and the
periderm, which corresponds to the adult spinous layer and is
marked by the onset of K1 and K10 expression (Bickenbach et al,
1995). Loricrin and ¢laggrin are ¢rst expressed between E16.5 and
E17.5 as the granular layer and stratum corneum form, creating a
water impermeable barrier (Rothnagel et al, 1987; Mehrel et al,
1990; Bickenbach et al, 1995). At E18.5 the epidermis is fully stra-
ti¢ed and the periderm is shed.
p63 IN EPIDERMAL DEVELOPMENT
Initiation of epidermal development at E9.5 coincides with the
onset of p63 expression in the single-layered surface ectoderm,
suggesting a role for p63 in early epidermal development. The
highest levels of p63 expression are observed in the apical ecto-
dermal ridge (AER), a specialized, pseudo-strati¢ed epithelial
structure required for limb bud outgrowth ( Johnson and Tabin,
1997; Mills et al, 1999; Yang et al, 1999). After E9.5, p63 continues
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to be expressed in the basal layer of the developing and adult epi-
dermis and other strati¢ed and pseudo-strati¢ed epithelia.
The importance of p63 in ectodermal development is under-
scored by the severe developmental defects observed in p63/
mice (Mills et al, 1999; Yang et al, 1999). Newborn mice lacking
functional p63 do not have strati¢ed and pseudo-strati¢ed epithe-
lia, lack epithelial appendages such as mammary glands, hair fol-
licles, and teeth, have truncated forelimbs, and do not have
hindlimbs. At birth, p63/mice do not have a recognizable epi-
dermis but possess a thin, single-cell layer covering the body, re-
sulting in dehydration and death within hours after birth. This
cell layer fails to express numerous epidermal di¡erentiation mar-
kers including K5, K14, K1, K10, loricrin, ¢laggrin, and involu-
crin, indicating a fundamental defect in epithelial lineage
development. As appendage development requires signaling be-
tween the ectoderm and the underlying mesenchyme, the defects
in appendage development in p63/ mice may be secondary to
the failure to develop strati¢ed epithelial structures, such as the
epidermis and the AER. Indeed, the expression patterns of var-
ious genes required for limb bud outgrowth suggest that impro-
per AER formation in p63/ mice results in a failure of the
ectoderm to participate in ectodermalmesenchymal signaling.
This, in turn, probably underlies the defects in limb morpho-
genesis observed in p63/mice.
This defect in epithelial lineage development has led to two,
not mutually exclusive, hypotheses concerning the potential role
of p63 in epidermal development. Patches of cells expressing the
terminal di¡erentiation markers loricrin, ¢laggrin, and involu-
crin were observed in the epidermis of E17.5 p63/ embryos
generated by Yang et al, suggesting that the embryonic p63/
epidermis undergoes a process of di¡erentiation before under-
going cell death (Yang et al, 1999). This observation led Yang et al
to suggest that p63 may play a pivotal role in maintaining the
epidermal stem cell population. Thus, the absence of squamous
epithelia in p63/ mice could be explained by a premature de-
pletion of the stem cell compartment resulting in a failure to
maintain strati¢ed epithelia. This hypothesis was strengthened
by clonal analysis of wild-type keratinocytes that demonstrated
exclusive expression of p63 in holoclones, thought to represent
the stem cell compartment of the epidermis (Barrandon and
Green, 1987; Pellegrini et al, 2001). Although these results are con-
sistent with a role for p63 in stem cell maintenance, de¢nitive
evidence has not been reported. An attractive alternative explana-
tion for the absence of squamous epithelia in p63/mice is that
p63 plays a critical role in the commitment of embryonic ecto-
derm to squamous epithelial lineages. In fact, although patches
of di¡erentiated cells were observed byYang et al (1999), we have
been unable to detect such patches at any stage during embryonic
development of p63/mice (Mills et al, 1999). In addition, recent
evidence suggests that p63 regulates the expression of several
genes potentially involved in epidermal development and di¡er-
entiation (Dohn et al, 2001; Nishi et al, 2001; Sasaki et al, 2001).
Therefore, a plausible role for p63 is the induction of a squamous
di¡erentiation program.
STRUCTURE OF p63
The understanding of the precise function of p63 in epithelial de-
velopment is complicated by the ¢nding that p63 is transcribed
into at least six di¡erent isoforms generated by alternative pro-
moter usage and alternative splicing (Fig 1) (Yang et al, 1998).
Alternative promoter use gives rise to two classes of p63 isoforms,
those containing an acidic amino terminus analogous to the p53
transactivation domain (TA isoforms) and those lacking this do-
main (DN isoforms). In addition, alternative splicing gives rise to
three di¡erent carboxy termini designated a, b, and g. The a car-
boxy terminus is the longest and contains a sterile amotif (SAM)
domain (Chi et al, 1999). SAM domains are protein interaction
motifs frequently found in proteins involved in development
and di¡erentiation, suggesting a role for p63a isoforms in these
processes.
p63 TARGET GENES
In vitro studies demonstrated that p63 is able to bind to the p53
response element (Bian and Sun, 1997; Zeng et al, 1998) contain-
ing two copies of the 10-mer PuPuPuC(A/T)(T/A)GPyPyPy se-
parated by two to eight nucleotides (el Deiry et al, 1992). The p53
response element in promoters of di¡erent p53 target genes can
contain as many as four mismatches. Interestingly, biochemical
studies on binding of p63 to p53 response elements of a subset
of p53 target genes demonstrated that, as opposed to p53, p63
has a higher a⁄nity for p53 response elements that contain more
mismatched nucleotides (e.g., Bax-1), suggesting that p53 and p63
may have overlapping as well as di¡erent transcriptional targets
(Zeng et al, 1998).
In addition to being able to bind to p53 response elements,
transient transactivation assays demonstrated that p63 can induce
transcription of several p53 responsive genes. As predicted from
their structures, these studies suggested that only TA isoforms
are capable of transactivating p53 target genes, whereas DN iso-
forms have a dominant-negative function (Yang et al, 1998). In ad-
dition, functional consequences of carboxy terminal variability
have been described. Most notably, TAp63a, which contains a
transactivation domain, is unable to transactivate p53 target genes
in transient transactivation assays. Although these experiments
provide valuable insight into the mechanism of action of p63, it
is well established that the activation of transfected promoter
constructs does not always re£ect the activation of endogenous
genes where chromatin remodeling occurs (Smith and Hager,
1997. In this context, it is of interest to note that recent transfec-
tion studies have identi¢ed target genes of p63 that are potentially
involved in epidermal di¡erentiation and development.
TAp63a was shown to induce expression of EphA2 tyrosine
kinase, which inhibits integrin-mediated cell adhesion, poten-
tially contributing to epidermal di¡erentiation (Miao et al, 2000;
Dohn et al, 2001). In addition, TAp63g was shown to induce ex-
pression of Jagged-1 and also to downregulate epidermal growth
factor receptor (EGFR) expression (Nishi et al, 2001; Sasaki et al,
2001). Jagged-1, a Notch ligand, activates Notch signaling, which
is thought to promote epidermal development (Powell et al, 1998;
Lowell et al, 2000). Downregulation of EGFR expression is
associated with epidermal di¡erentiation as demonstrated by
the sharp decrease of EGFR expression levels in the suprabasal
layers compared to the basal layer of the epidermis (Zambruno
et al, 1990). In summary, these data demonstrate that p63 target
genes are potentially involved in epidermal development and
di¡erentiation.
Figure1. Structure of p63 isoforms. Alternative promoter usage gives
rise to p63 isoforms containing a transactivation domain and isoforms lack-
ing this domain. Three carboxy termini are generated by alternative spli-
cing. Exons are color coded indicating the functional domains. Adapted
fromYang et al (2000).
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ROLE OF p63 IN HUMAN DISEASE
It is well known that many developmental genes continue to play
an important role in regulation of cell growth and di¡erentiation
after embryogenesis. The dysregulation of these genes has been
associated with congenital abnormalities and cancer. Although
mutations in p63 are rare in human cancers (Hagiwara et al,
1999), dysregulated expression of p63, sometimes in conjunction
with ampli¢cation of its genomic region at 3q27^28, is fre-
quently observed in a subset of human epithelial cancers (Crook
et al, 2000; Hibi et al, 2000; Park et al, 2000;Yamaguchi et al, 2000).
The isoform targeted for overexpression appears to be DNp63a,
which, in this context, may downregulate expression of p53 tar-
get genes thereby preventing the induction of cell cycle arrest and
apoptosis. Interestingly, we have demonstrated a reduction in ul-
traviolet-B-induced apoptosis in mice expressing DNp63a under
control of the mouse loricrin promoter suggesting that domi-
nant-negative isoforms of p63 may play an oncogenic role in
epithelial tissues (Liefer et al, 2000).
Congenital abnormalities associated with p63 dysregulation
include a subset of ectodermal dysplasias. Ectodermal dysplasias
comprise a large and heterogeneous group of conditions charac-
terized by hereditary, developmental disturbances that a¡ect tis-
sues of ectodermal origin. Mutations in p63 have been shown to
underlie ectrodactyly, ectodermal dysplasia and cleft lip (EEC),
limb^mammary syndrome (LMS), split handsplit foot malfor-
mation (SHFM), ankyloblepharon ectodermal dysplasia and cleft-
ing (AEC or HayWells disease), and acro-dermato-ungual-
lacrimal^tooth syndrome (ADULT). Each of these syndromes
has been shown to result from di¡erent types of p63 mutations.
Missense mutations in the DNA-binding domain of p63 result in
EEC (Celli et al, 1999) or ADULT syndrome (Duijf et al, 2002),
missense mutations in the SAM domain result in AEC (McGrath
et al, 2001), frame-shift mutations in or near the SAM result in
LMS (van Bokhoven et al, 2001), whereas p63 mutations in
SHFM are dispersed throughout the gene (Ianakiev et al, 2000).
Expression constructs encoding individual p63 isoforms with
each identi¢ed mutation were used for transactivation assays
using a reporter gene under control of the p53 response element.
Only subtle di¡erences between AEC and EEC mutations with
respect to transactivation were observed. Interestingly, the mis-
sense mutation observed in ADULTsyndrome was demonstrated
to result in a gain-of-function of the DNp63g isoform (Duijf et al,
2002). To gain a better understanding of the functional implica-
tions of these p63 mutations, it is imperative to understand the
physiologic role of p63 in skin development.
In summary, the precise role of p63 in epidermal development
is still elusive and may include stem cell maintenance and/or the
induction of a squamous di¡erentiation program. A ¢rst step to-
wards the understanding of the role of p63 in epidermal develop-
ment is to identify the isoform(s) responsible for this process. In
addition, understanding the role of p63 will be greatly facilitated
by the identi¢cation of p63 downstream genes as well as the pro-
teins binding to p63. Comparisons between the target genes and
protein-binding partners of wild-type and mutant p63 will pro-
vide insight into the molecular basis of ectodermal dysplasias and
may identify therapeutic targets.
LOCATION OF EPIDERMAL STEM CELLS
An equally important process required for epidermal develop-
ment and di¡erentiation is the regulation of epidermal stem cell
fate. Recent progress has been made in identifying the molecules
involved in stem cell fate decisions allowing for a better under-
standing of this process.
The characteristics of a stem cell include a high capacity for
self-renewal throughout adult life and the ability to produce
daughter cells that undergo terminal di¡erentiation (Lajtha,
1979). Stem cells have been found in permanently renewing tis-
sues including the hemopoietic system, the small intestine lining,
and the epidermis ( Jones and Watt, 1993). Epidermal stem cells
give rise to transit amplifying cells, which have a high potential
to undergo di¡erentiation and a low potential for self-renewal
compared to stem cells ( Jones and Watt, 1993). Epidermal stem
cells have been shown to express high levels of b1 integrin com-
pared to transit amplifying cells. This has provided a way to iso-
late epidermal stem cells based on their adhesiveness to
extracellular matrix proteins ( Jones and Watt, 1993; Bickenbach
and Chism, 1998).
In the epidermis, cells residing in the bulge and bulb regions
of hair follicles have characteristics of stem cells (Reynolds and
Jahoda, 1991; Hardy, 1992). Label retaining experiments demon-
strated that cells residing in the bulge of mouse pelage follicles
are slow cycling cells. The progeny of these slow cycling cells
contribute to hair growth of mouse pelage follicles and play a
role in closure of epidermal wounds (Taylor et al, 2000). Addi-
tional evidence to suggest that epidermal stem cells reside in the
bulge region of the hair follicles was provided by a series of ele-
gant experiments performed by Oshima et al (2001). Chimeric
hair follicles, created from a wild-type vibrissal follicle with an
amputated bulge region and the bulge region from a Rosa 26 vi-
brissal follicle, were transplanted into athymic mice. Rosa 26
transgenic mice constitutively express a lacZ reporter gene (Frie-
drich and Soriano, 1991). Therefore the Rosa 26 bulge region pro-
vided labeled cells whose migration could be monitored in the
wild-type follicle. Four weeks after the transplant, labeled cells
could be seen migrating along the hair follicle towards the hair
bulb and the epidermis. After 6 weeks, labeled cells were found
in the hair bulb, sebaceous glands, and epidermis (Oshima et al,
2001). These data suggest that epidermal stem cells reside in the
bulge region of hair follicles fromwhere they migrate to generate
hair follicles, sebaceous glands, and epidermis (Fig 2).
Wnt SIGNALING REGULATES EPIDERMAL STEM CELL
FATE DECISIONS
Although there are strong data suggesting the location of epider-
mal stem cells, we are just starting to determine how epidermal
stem cell fate is regulated. There is evidence to suggest that pro-
teins involved in theWnt signaling pathway have a role in epider-
mal stem cell fate decisions (Gat et al, 1998; Kishimoto et al, 2000).
TheWnt signaling pathway is important for body axis formation
and for the development of the central nervous system, limbs,
and mammary glands. In addition, this pathway has been found
to regulate the hair cycle (Kishimoto et al, 2000). TheWnt signal-
ing pathway is activated by the binding of a glycoprotein of the
Figure 2. Multipotent stem cells generate hair follicles, sebaceous
glands, and the epidermis. Multipotent stem cells (red) residing in the
bulge region of the hair follicle migrate (pink) towards the hair bulb region
and epidermis, giving rise to di¡erentiated cells (purple) that populate the
hair follicle, sebaceous gland, and epidermis. Inset shows that, in the epi-
dermis, stem cells (pink) give rise to transit amplifying cells (blue), which
proliferate and then di¡erentiate giving rise to progeny at progressive
stages of maturation (multiple shades of green).
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Wnt protein family to a receptor of the frizzled transmembrane
protein family. A signal is transduced to dishevelled, a cytoplas-
mic protein, which in turn represses the activity of glycogen
synthase kinase-3b, thereby stabilizing b-catenin. In the absence
of Wnt signaling, phosphorylation of b-catenin by glycogen
synthase kinase-3b targets b-catenin for degradation via ubiquiti-
nation. b-Catenin, ¢rst identi¢ed as a cell-adhesion protein, is
stabilized byWnt signaling. After stabilization, b-catenin translo-
cates to the nucleus where it binds to coactivators from the Lef/
TCF family and activates the transcription of target genes (re-
viewed in Polakis, 2000). In the absence of this binding between
Lef/TCF transcription factors and b-catenin, the Lef/TCF tran-
scription factors are associated with members of the Groucho fa-
mily of transcription repressor proteins (Akiyama, 2000).
There is evidence to suggest that various proteins involved in
theWnt signaling pathway regulate epidermal stem cell fate deci-
sions (DasGupta and Fuchs, 1999; Kishimoto et al, 2000). Tcf3, a
member of the Lef/TCF family, is expressed in cells in the bulge
and outer root sheath regions of the hair follicle (Merrill et al,
2001). As the Tcf3 positive cells in the bulge migrate along the
hair follicle to the epidermis and sebaceous gland,Tcf3 expression
is lost. This suggests that Tcf3 plays a role in epidermal stem cell
maintenance.
Expression of another member of the Lef/TCF family, Lef1, is
found in the hair producing progenitors of the hair follicle (Das-
Gupta and Fuchs, 1999). In transgenic mice that express stabilized
b-catenin in the epidermis there is apparent hair morphogenesis,
which usually only takes place during embryogenesis when the
dermal papilla and upper portion of the follicle are established
(Gat et al, 1998). Likewise, transgenic mice expressing Lef1 under
control of the K14 promoter, which targets transgene expression
to the hair follicle and basal layer of the epidermis, exhibited hair
germ-like invaginations in the epidermis (Zhou et al, 1995). In
mice overexpressing a dominant-negative form of Lef1, a decrease
in hair and an increase in sebaceous glands were observed. In ad-
dition, Lef1 knockout mice exhibit a marked reduction in the
number of hair follicles (van Genderen et al, 1994). Altogether,
data from these mouse models indicate that b-catenin/Lef1 tran-
scriptional activation is required for hair di¡erentiation.
c-Myc INFLUENCES EPIDERMAL STEM CELL FATE
DECISIONS
In addition toTcf3 and Lef1, there is evidence that c-Myc plays a
role in regulating epidermal stem cell fate decisions. c-Myc, a
known target of Wnt signaling, is a proto-oncogene that encodes
the Myc transcription factor known to induce growth, prolifera-
tion, transformation, and apoptosis (He et al, 1998; Eisenman,
2001). The promoter of c-Myc contains binding sites for Tcf-4,
which allow for induction of c-Myc expression by b-catenin
(He et al, 1998; Akiyama, 2000). In the absence of b-catenin,Tcf4
is able to bind to the c-Myc promoter and repress transcription
(He et al, 1998). It has been shown that c-Myc is able to induce
di¡erentiation of epidermal stem cells in vitro (Gandarillas and
Watt, 1997). Mice with targeted overexpression of c-Myc in the
hair follicles and basal layer of the epidermis exhibit epidermal
hyperplasia, hair loss, and an increase in sebaceous gland size and
number (Fig 3) (Arnold and Watt, 2001Waikel et al, 2001). This
suggests that c-Myc promotes the di¡erentiation of stem cells into
epidermal and sebaceous lineages at the expense of hair follicles.
c-Myc TARGET GENES
Although numerous putative target genes of c-Myc have been
identi¢ed, the target genes of c-Myc that are involved in stem cell
fate decisions are currently unknown. Besides its role in the reg-
ulation of stem cell fate decisions, c-Myc is involved in a wide
variety of cellular processes, which is re£ected by the identi¢ca-
tion of target genes involved in cell growth, proliferation, and
apoptosis (Eisenman, 2001). More speci¢cally, the recent use of
microarray technology has uncovered potential target genes of
c-Myc that are required for cell cycle progression including genes
involved in protein synthesis, lipid metabolism, DNA synthesis,
protection from oxidative stress, and signal transduction (Schuh-
macher et al, 2001). In addition, microarray analysis of the expres-
sion pro¢le of c-Myc-induced tumors identi¢ed genes involved
in cell cycle progression as target genes of c-Myc in carcinogen-
esis (Schuldiner and Benvenisty, 2001). Despite the identi¢cation
of a vast array of c-Myc target genes, the target genes of c-Myc
involved in stem cell fate decisions are still elusive.
SUMMARY
As a downstream target of theWnt signaling pathway, c-Myc is a
potential candidate gene involved in stem cell fate decisions.
Identi¢cation of target genes of c-Myc involved in epidermal
and sebaceous gland di¡erentiation will provide further insight
into the mechanisms by which the Wnt signaling pathway con-
trols stem cell fate decisions. In addition, understanding the role
of p63 in epidermal development will help determine its impact
on stem cell maintenance and epithelial di¡erentiation.These stu-
dies, combined with others, will provide new insight into the
regulatory mechanisms involved in epidermal development and
di¡erentiation and might identify therapeutic targets for a variety
of skin disorders.
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